| abstract |
The present invention relates to novel 2- (1,2,4-triazol-1-yl) thiadiazole derivatives of general formula (I), pharmaceutical compositions comprising first-line active ingredients containing such an active ingredient, and a method for preparing the active ingredient. In general formula (I), R 1 is a hydrogen atom, a alkyl radical or a phenyl tube substituted in the case where it is substituted with 1-3 crystals, from which the doping gene, hydrofluoric acid powder, nitrile coat, alkyloxy powder, alkylamine tube coat, or diaalkylamine tube, may be one of R 2 and R 3. substitutable amine powder, the other substituent is an amine ring or a 5-10 membered saturated heterocyclic ring radical having a nitrogen atom and / or xenogene and / or sulfur atom attached thereto, substituted in the case of a substitution by an alkylpipe, a phenyl tube or a halogen phenyl phenyl tube; a radical of the general formula SR, from which R is alkyl alkenyl or alkynyl, from which, in the given case, the alkylpowder is replaced by a phenylpiper or substituted by a pseudophenylamine and, in the given case, one or both amines; hornbeam replaced with one or two stamens. ŕ |